Boston Scientific
U.S.-based medical device company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Boston Scientific?
Summarize this article for a 10 year old
42°21′37.3″N 71°33′32.6″W Boston Scientific Corporation ("BSC"), headquartered in Watertown, Massachusetts and incorporated in Delaware,[2] is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries.[3] With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator (ICD) which they call the EMBLEM subcutaneous implantable defibrillator (S-ICD).[4][5]
This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (December 2018) |
Company type | Public |
---|---|
ISIN | US1011371077 |
Industry | Medical device |
Founded | June 29, 1979; 44 years ago (1979-06-29) in Watertown, Massachusetts |
Founders | |
Headquarters | Marlborough, Massachusetts, U.S. |
Key people | |
Revenue | US$14.24 billion (2023)[1] |
US$2.343 billion (2023)[1] | |
US$1.592 billion (2023)[1] | |
Total assets | US$35.14 billion (2023)[1] |
Total equity | US$19.28 billion (2023)[1] |
Number of employees | c. 48,000[1] (2023) |
Website | bostonscientific |